Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYSCHEM (I). vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SYSCHEM (I).   ACTAVIS
EQUITY SHARE DATA
    SYSCHEM (I).
Mar-23
ACTAVIS
Dec-18
SYSCHEM (I)./
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs6516,159-   
Low Rs1110,840-   
Sales per share (Unadj.) Rs30.33,963.8-  
Earnings per share (Unadj.) Rs1.4-1,276.8-  
Cash flow per share (Unadj.) Rs2.3417.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs7.016,349.0-  
Shares outstanding (eoy) m31.89332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.4 36.9%   
Avg P/E ratio x27.0-10.6 -255.0%  
P/CF ratio (eoy) x16.932.3 52.2%  
Price / Book Value ratio x5.50.8 660.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,2174,489,898 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m440-   
Avg. sales/employee Rs Th078,010.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,127.1-  
INCOME DATA
Net Sales Rs m9671,318,372 0.1%  
Other income Rs m225,212 0.0%   
Total revenues Rs m9701,343,584 0.1%   
Gross profit Rs m8634,548 0.3%  
Depreciation Rs m27563,576 0.0%   
Interest Rs m076,078 0.0%   
Profit before tax Rs m62-579,893 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,896 0.0%   
Tax Rs m16-7,349 -0.2%   
Profit after tax Rs m45-424,648 -0.0%  
Gross profit margin %8.92.6 341.1%  
Effective tax rate %26.61.3 2,100.8%   
Net profit margin %4.7-32.2 -14.5%  
BALANCE SHEET DATA
Current assets Rs m586540,727 0.1%   
Current liabilities Rs m430478,345 0.1%   
Net working cap to sales %16.14.7 340.6%  
Current ratio x1.41.1 120.6%  
Inventory Days Days420 20.2%  
Debtors Days Days1,58266 2,386.5%  
Net fixed assets Rs m319149,232 0.2%   
Share capital Rs m3190-   
"Free" reserves Rs m-960-   
Net worth Rs m2235,437,670 0.0%   
Long term debt Rs m161,914,801 0.0%   
Total assets Rs m9048,500,316 0.0%  
Interest coverage x147.5-6.6 -2,226.6%   
Debt to equity ratio x0.10.4 20.4%  
Sales to assets ratio x1.10.2 689.8%   
Return on assets %5.0-4.1 -122.9%  
Return on equity %20.2-7.8 -259.1%  
Return on capital %25.9-4.8 -535.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-85471,005 -0.0%  
From Investments Rs m91258,756 0.0%  
From Financial Activity Rs mNA-808,385 0.0%  
Net Cashflow Rs m5-78,232 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare SYSCHEM (I). With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SYSCHEM (I). With: UNJHA FORMUL  ROOPA INDUSTRIES  MANKIND PHARMA  SMRUTHI ORGANICS  ADVIK LABORS  



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.